{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T14:51:15Z","timestamp":1711637475371},"reference-count":13,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jocn-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.jocn.2015.05.003","type":"journal-article","created":{"date-parts":[[2015,6,24]],"date-time":"2015-06-24T18:53:51Z","timestamp":1435172031000},"page":"1669-1671","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Surgical management of malignant cerebral edema secondary to immune reconstitution inflammatory syndrome from natalizumab-associated progressive multifocal encephalopathy"],"prefix":"10.1016","volume":"22","author":[{"given":"Lee A.","family":"Tan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Demetrius K.","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2015.05.003_b0005","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/brain\/81.1.93","article-title":"Progressive multifocal leuko-encephalopathy: a hitherto unrecognized complication of chronic lymphatic leukaemia and Hodgkin\u2019s disease","volume":"81","author":"Astrom","year":"1958","journal-title":"Brain"},{"key":"10.1016\/j.jocn.2015.05.003_b0010","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/S0140-6736(71)91777-6","article-title":"Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy","volume":"1","author":"Padgett","year":"1971","journal-title":"Lancet"},{"key":"10.1016\/j.jocn.2015.05.003_b0015","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1093\/infdis\/127.4.467","article-title":"Prevalence of antibodies in human sera against JC virus, an isolate from a case of progressive multifocal leukoencephalopathy","volume":"127","author":"Padgett","year":"1973","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jocn.2015.05.003_b0020","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1212\/01.wnl.0000343510.08643.74","article-title":"PML-IRIS in patients with HIV infection: clinical manifestations and treatment with steroids","volume":"72","author":"Tan","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2015.05.003_b0025","doi-asserted-by":"crossref","first-page":"668","DOI":"10.3389\/fimmu.2014.00668","article-title":"Immunological markers for PML prediction in MS patients treated with natalizumab","volume":"5","author":"Antoniol","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.jocn.2015.05.003_b0030","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/ana.24051","article-title":"Progressive multifocal leukoencephalopathy after natalizumab discontinuation","volume":"75","author":"Fine","year":"2014","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2015.05.003_b0035","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S1474-4422(10)70028-4","article-title":"Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases","volume":"9","author":"Clifford","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jocn.2015.05.003_b0040","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1212\/WNL.0b013e31822e55e7","article-title":"Immune reconstitution inflammatory syndrome in natalizumab-associated PML","volume":"77","author":"Tan","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2015.05.003_b0045","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/ana.24286","article-title":"Anti-JC virus antibody levels in serum or plasma further define risk of natalizumab-associated progressive multifocal leukoencephalopathy","volume":"76","author":"Plavina","year":"2014","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2015.05.003_b0050","doi-asserted-by":"crossref","first-page":"620","DOI":"10.47102\/annals-acadmedsg.V41N12p620","article-title":"Progressive Multifocal Leukoencephalopathy with Immune Reconstitution Inflammatory Syndrome (PML-IRIS): two case reports of successful treatment with mefloquine and a review of the literature","volume":"41","author":"Young","year":"2012","journal-title":"Ann Acad Med Singapore"},{"key":"10.1016\/j.jocn.2015.05.003_b0055","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/j.jocn.2013.12.031","article-title":"Mefloquine improved progressive multifocal leukoencephalopathy in a patient with immunoglobulin A nephropathy","volume":"21","author":"Shin","year":"2014","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.jocn.2015.05.003_b0060","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1161\/STROKEAHA.113.002014","article-title":"Surgical decompression for space-occupying cerebral infarction: outcomes at 3years in the randomized HAMLET trial","volume":"44","author":"Geurts","year":"2013","journal-title":"Stroke"},{"key":"10.1016\/j.jocn.2015.05.003_b0065","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1161\/STROKEAHA.107.485649","article-title":"Decompressive Surgery for the Treatment of Malignant Infarction of the Middle Cerebral Artery (DESTINY): a randomized, controlled trial","volume":"38","author":"J\u00fctler","year":"2007","journal-title":"Stroke"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586815002301?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586815002301?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T19:28:34Z","timestamp":1691782114000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586815002301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":13,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S0967586815002301"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2015.05.003","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Surgical management of malignant cerebral edema secondary to immune reconstitution inflammatory syndrome from natalizumab-associated progressive multifocal encephalopathy","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2015.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}